Pier Capital’s Aehr Test Systems AEHR Stock Holding History

Pier Capital’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.8M	Sell	60,394 -66,597	-52%	-$6.09M	0.77%	65
2026 Q1	$4.71M	Sell	126,991 -84,628	-40%	-$2.71M	0.78%	68
2025 Q4	$4.27M	Sell	211,619 -159,336	-43%	-$3.85M	0.68%	70
2025 Q3	$11.2M	Sell	370,955 -34,977	-9%	-$757K	1.75%	3
2025 Q2	$5.25M	Buy	405,932 +55,861	+16%	+$532K	0.8%	63
2025 Q1	$2.55M	Sell	350,071 -174,160	-33%	-$1.93M	0.43%	87
2024 Q4	$8.72M	Buy	524,231 +112,154	+27%	+$1.5M	1.24%	33
2024 Q3	$5.3M	Buy	412,077 +103,144	+33%	+$1.49M	0.75%	78
2024 Q2	$3.45M	Buy	308,933 +189,369	+158%	+$2.21M	0.51%	89
2024 Q1	$1.48M	Buy	+119,564	New	+$1.99M	0.2%	97
2023 Q4	–	Sell	-95,733	Closed	-$4.37M	–	118
2023 Q3	$4.37M	Sell	95,733 -43,976	-31%	-$2.04M	0.71%	72
2023 Q2	$5.76M	Buy	139,709 +32,456	+30%	+$1.06M	0.83%	65
2023 Q1	$3.33M	Sell	107,253 -31,564	-23%	-$1.02M	0.5%	94
2022 Q4	$2.79M	Buy	+138,817	New	+$2.97M	0.46%	90

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pier Capital's AEHR Position: Q2 2026 in Review

Pier Capital reduced its Aehr Test Systems (AEHR) stake by 52% in Q2 2026, selling an estimated $6.09M and leaving 60,394 shares worth $5.8M. The position accounts for 0.77% of the portfolio, ranked #65.

Pier Capital first reported a position in AEHR in Q4 2022 and has held it in 14 quarters since. The position peaked at $11.2M in Q3 2025. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

Pier Capital held 60,394 shares of Aehr Test Systems worth $5.8M as of Q2 2026.
Pier Capital sold 66,597 Aehr Test Systems shares in Q2 2026, an estimated $6.09M.
Aehr Test Systems made up 0.77% of Pier Capital's portfolio in Q2 2026, its #65 holding.
Pier Capital first reported a position in Aehr Test Systems in Q4 2022 and has held it in 14 quarters since.
Pier Capital's Aehr Test Systems position peaked at $11.2M in Q3 2025.
262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Pier Capital's 13F filing for Q2 2026, filed 5 Aug 2026.